Most significantly regulated genes include targets of ER regulation and genes previously associated with breast cancer progression and poor outcomes, including upregulation of SULF1, SCIN, ATP8A2, GPER1, and CLIC3 (49, , , –53) (Dataset S2A). This evidence concerns the gene SULF1 and breast carcinoma.